Autres inhibiteurs
Cette catégorie englobe une grande variété d'inhibiteurs qui ne rentrent pas dans les classifications standard mais qui sont néanmoins cruciaux pour diverses recherches biochimiques et pharmacologiques. Ces inhibiteurs peuvent cibler des voies, des enzymes et des interactions moléculaires uniques ou moins étudiés, fournissant des outils précieux pour des domaines de recherche spécialisés. Chez CymitQuimica, nous offrons une sélection diversifiée d'inhibiteurs de haute qualité ciblant de multiples objectifs biologiques et disciplines de recherche, vous permettant d'explorer de nouvelles avenues thérapeutiques et d'approfondir votre compréhension des processus biologiques complexes.
37931 produits trouvés pour "Autres inhibiteurs"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
CYY292
CAS :<p>CYY292 is a chemical compound acting as an inhibitor of PDGFRα, PDGFRβ, FGFR1, -2, and -3, with respective IC50 values of 5.35, 4.6, 28, 28, and 78 nM.</p>Formule :C24H28N8OCouleur et forme :SolidMasse moléculaire :444.53CIAC001
CAS :<p>CIAC001, a pyruvate kinase PKM2 inhibitor, exhibits anti-neuroinflammatory properties.</p>Formule :C20H25N3O2Couleur et forme :SolidMasse moléculaire :339.43Tauro-Obeticholic Acid sodium
CAS :<p>Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid.</p>Formule :C28H48NO6S·NaCouleur et forme :SolidMasse moléculaire :549.74HMR 1556
CAS :<p>HMR 1556 is a chromanol derivative and is an IKs blocker (IC50s of 10.5 nM and 34 nM in canine and guinea pig left ventricular myocytes, respectively).</p>Formule :C17H24F3NO5SCouleur et forme :SolidMasse moléculaire :411.44I-BET282
CAS :<p>BET-IN-1 is a bromodomain inhibitor extracted from patent WO/2013024104A1 (example 2, plC50: 6.0 - 7.0).</p>Formule :C25H30N4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :450.53URAT1 inhibitor 5
CAS :<p>URAT1 Inhibitor 5 (compound 16) serves as a powerful inhibitor of URAT1 and is utilized in hyperuricemia research [1].</p>Formule :C18H14BrN3O2SCouleur et forme :SolidMasse moléculaire :416.29SHP2-IN-14
CAS :<p>SHP2-IN-14 (compound 27) is a potent, orally active allosteric inhibitor of SHP2, displaying strong anti-tumor activity with an IC50 of 7 nM.</p>Formule :C22H20Cl2N8OCouleur et forme :SolidMasse moléculaire :483.3580-O16B
CAS :<p>80-O16B, an ionizable cationic lipid featuring disulfide bonds, is utilized in the preparation of lipid nanoparticles (LNP) [1].</p>Formule :C39H78N2O4S4Couleur et forme :SolidMasse moléculaire :767.31LM2I
CAS :<p>LM2I, a derivative of Spinosyn A (SPA), serves both as an argininosuccinate synthase (ASS1) enzyme activator and a tumor inhibitor through direct interaction</p>Formule :C47H77N3O11Couleur et forme :SolidMasse moléculaire :860.13FLT3-IN-19
CAS :<p>FLT3-IN-19 (Comp 50) is a potent, selective inhibitor of FLT3, demonstrating an IC50 value of 0.213 nM, and is applicable in research pertaining to acute</p>Formule :C22H26N8OCouleur et forme :SolidMasse moléculaire :418.49DDO-2213
CAS :<p>DDO-2213 is a potent, orally active inhibitor of the WDR5-MLL1 interaction, demonstrating an IC50 of 29 nM and a Kd of 72.9 nM against WDR5.</p>Formule :C24H27ClFN7OCouleur et forme :SolidMasse moléculaire :483.97RIOK2-IN-2
CAS :<p>RIOK2-IN-2 (8) functions as an inhibitor of RIOK2, exhibiting IC50 values of 3.02 μM in MKN-1 cells and 5.34 μM in MOLT4 cells [1].</p>Formule :C27H23F3N6O2Couleur et forme :SolidMasse moléculaire :520.51And1-IN-1
CAS :<p>And1-IN-1, also known as compound III, is a potent inhibitor of And1 [1].</p>Formule :C15H11BCl2O2Couleur et forme :SolidMasse moléculaire :304.96Antitumor photosensitizer-2
CAS :<p>Compound 11, also known as Antitumor Photosensitizer-2, is a potent photosensitizer with remarkable photodynamic anti-tumor properties and minimal skin photo-</p>Formule :C40H47N5O7Couleur et forme :SolidMasse moléculaire :709.83FOXM1-IN-2
CAS :<p>FOXM1-IN-2, a FOXM1 inhibitor, exhibits antineoplastic activity [1].</p>Formule :C48H47F4N7O12SCouleur et forme :SolidMasse moléculaire :1021.99MDVN1003
CAS :<p>MDVN1003 inhibits BTK & PI3Kδ in B cells, blocking NHL growth; it kills lymphoma cells, not erythroblasts.</p>Formule :C22H20FN7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :417.44LT-540-717
CAS :<p>LT-540-717 (compound 32), a potent FLT3 inhibitor (IC50=0.62 nM), exhibits antiproliferative activity and effectively inhibits various acquired FLT3 mutations,</p>Formule :C24H24N8O2Couleur et forme :SolidMasse moléculaire :456.5HPK1-IN-38
CAS :<p>HPK1-IN-38 (compound 15) is an inhibitor of MAP4K1/HPK1, suitable for research into disorders related to HPK1 [1].</p>Formule :C29H29N5O3Couleur et forme :SolidMasse moléculaire :495.57Antitumor agent-136
CAS :<p>Antitumor Agent-136 (Compound 17), a broad-spectrum antitumor agent and NAMPT inhibitor, exhibits potent activity with an IC50 of 9.5 nM. It efficiently lowers intracellular and extracellular NAMPT protein levels via the ubiquitin proteasome pathway, achieving effective tumor inhibition [1].</p>Formule :C58H76N10O11S3Couleur et forme :SolidMasse moléculaire :1185.48Ac4GalNAlk
CAS :<p>Ac4GalNAlk, a weakly alkyne-labeled reagent for metabolic oligosaccharide engineering (MOE), facilitates the detection of protein glycosylation by promoting nucleotide-sugar biosynthesis and enhancing bioorthogonal cell surface markers. It is activated by cellular biosynthetic machinery into nucleotide sugars, subsequently enabling the tracing of glycoproteins in bioorthogonal chemistry [1].</p>Formule :C19H25NO10Couleur et forme :SolidMasse moléculaire :427.4
